Company: DGLY
Filing Date: 2025-05-20
Form Type: 10-Q
Source: 0001641172-25-011765
Chunk: 140

Company: DIGITAL ALLY, INC.
Filing Date: 2025-05-20
Form: 10-Q
Item: Part I, Item 8
Chunk 140
---
    28

    Warrants  
    Weighted
                                                                                average exercise price 
  
    Balance, January 1, 2024 
     56,250  
    $130.00 
  
    Issued 
     —  
     — 
  
    Exercised 
     —  
     — 
  
    Terminated/Cancelled 
     —  
     — 
  
    Balance, March 31, 2024 
     56,250  
    $130.00 

The total
intrinsic value of all outstanding warrants aggregated $-0-
and $2,128,320
as of March 31, 2025 and December 31, 2024, respectively and the weighted average remaining term was 48.5
and 52.3
months as of March 31, 2025 and 2024, respectively.

The following table summarizes
the range of exercise prices and weighted average remaining contractual life for outstanding and exercisable warrants to purchase shares
of Common Stock as of March 31, 2025:

 SCHEDULE
OF RANGE OF EXERCISE PRICES AND WEIGHTED AVERAGE REMAINING CONTRACTUAL LIFE OF WARRANTS

    Outstanding and exercisable warrants
  
    Exercise price  
    Number of warrants  
    Weighted
                                                                                average remaining contractual life
  
    $10.04  
     298,805  
    4.2 years
  
    $110,00  
     18,750  
    3.0 years
  
    $130.00  
     18,750  
    3.0 years
  
    $150.00  
     18,750  
    3.0 years

     355,055  
    4.0 years

2025 Purchase Warrants

 On February 13,
2025, the Company issued pre-funded units, each consisting of one-prefunded warrant (to purchase a total of 4,907,500
shares of Common Stock), one Series A warrant and one Series B warrant along with the sale of units, each consisting of one share of
Common Stock, one Series A warrant and one Series B warrant. The Series A and Series B warrants were exercisable only upon receipt
of stockholder approval (the “Stockholder Approval”) to approve each of (i) certain terms in the Series A warrants and
Series B warrants and the